vs
Side-by-side financial comparison of First Bancorp, Inc (FNLC) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
First Bancorp, Inc is the larger business by last-quarter revenue ($25.8M vs $20.6M, roughly 1.3× Entrada Therapeutics, Inc.). First Bancorp, Inc runs the higher net margin — 39.4% vs -84.4%, a 123.7% gap on every dollar of revenue. On growth, First Bancorp, Inc posted the faster year-over-year revenue change (17.5% vs -65.2%). First Bancorp, Inc produced more free cash flow last quarter ($34.6M vs $-39.7M). Over the past eight quarters, First Bancorp, Inc's revenue compounded faster (18.1% CAGR vs 6.4%).
Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
FNLC vs TRDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.8M | $20.6M |
| Net Profit | $10.2M | $-17.3M |
| Gross Margin | — | — |
| Operating Margin | 48.1% | -106.0% |
| Net Margin | 39.4% | -84.4% |
| Revenue YoY | 17.5% | -65.2% |
| Net Profit YoY | 39.7% | -173.8% |
| EPS (diluted) | $0.91 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.8M | — | ||
| Q3 25 | $24.5M | — | ||
| Q2 25 | $22.5M | — | ||
| Q1 25 | $21.8M | $20.6M | ||
| Q4 24 | $22.0M | $37.4M | ||
| Q3 24 | $20.5M | $19.6M | ||
| Q2 24 | $19.2M | $94.7M | ||
| Q1 24 | $18.5M | $59.1M |
| Q4 25 | $10.2M | — | ||
| Q3 25 | $9.1M | — | ||
| Q2 25 | $8.1M | — | ||
| Q1 25 | $7.1M | $-17.3M | ||
| Q4 24 | $7.3M | $1.1M | ||
| Q3 24 | $7.6M | $-14.0M | ||
| Q2 24 | $6.2M | $55.0M | ||
| Q1 24 | $6.0M | $23.5M |
| Q4 25 | 48.1% | — | ||
| Q3 25 | 45.2% | — | ||
| Q2 25 | 43.7% | — | ||
| Q1 25 | 39.3% | -106.0% | ||
| Q4 24 | 39.5% | -15.7% | ||
| Q3 24 | 44.6% | -110.7% | ||
| Q2 24 | 38.8% | 56.4% | ||
| Q1 24 | 39.3% | 35.7% |
| Q4 25 | 39.4% | — | ||
| Q3 25 | 37.0% | — | ||
| Q2 25 | 35.8% | — | ||
| Q1 25 | 32.5% | -84.4% | ||
| Q4 24 | 33.1% | 3.0% | ||
| Q3 24 | 36.9% | -71.7% | ||
| Q2 24 | 32.1% | 58.1% | ||
| Q1 24 | 32.5% | 39.7% |
| Q4 25 | $0.91 | — | ||
| Q3 25 | $0.81 | — | ||
| Q2 25 | $0.72 | — | ||
| Q1 25 | $0.63 | $-0.42 | ||
| Q4 24 | $0.66 | $-0.20 | ||
| Q3 24 | $0.68 | $-0.35 | ||
| Q2 24 | $0.55 | $1.55 | ||
| Q1 24 | $0.54 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $67.8M |
| Total DebtLower is stronger | $95.5M | — |
| Stockholders' EquityBook value | $283.1M | $417.3M |
| Total Assets | $3.2B | $486.5M |
| Debt / EquityLower = less leverage | 0.34× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $67.8M | ||
| Q4 24 | — | $101.2M | ||
| Q3 24 | — | $78.0M | ||
| Q2 24 | — | $185.3M | ||
| Q1 24 | — | $68.4M |
| Q4 25 | $95.5M | — | ||
| Q3 25 | $95.5M | — | ||
| Q2 25 | $95.0M | — | ||
| Q1 25 | $70.0M | — | ||
| Q4 24 | $95.0M | — | ||
| Q3 24 | $95.0M | — | ||
| Q2 24 | $70.0M | — | ||
| Q1 24 | $70.0M | — |
| Q4 25 | $283.1M | — | ||
| Q3 25 | $274.6M | — | ||
| Q2 25 | $265.5M | — | ||
| Q1 25 | $259.7M | $417.3M | ||
| Q4 24 | $252.5M | $428.7M | ||
| Q3 24 | $256.8M | $422.4M | ||
| Q2 24 | $244.7M | $429.9M | ||
| Q1 24 | $242.6M | $269.4M |
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.2B | — | ||
| Q2 25 | $3.2B | — | ||
| Q1 25 | $3.2B | $486.5M | ||
| Q4 24 | $3.2B | $526.3M | ||
| Q3 24 | $3.1B | $554.6M | ||
| Q2 24 | $3.1B | $582.0M | ||
| Q1 24 | $3.0B | $510.8M |
| Q4 25 | 0.34× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.36× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.38× | — | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.29× | — | ||
| Q1 24 | 0.29× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $37.8M | $-38.5M |
| Free Cash FlowOCF − Capex | $34.6M | $-39.7M |
| FCF MarginFCF / Revenue | 133.9% | -192.9% |
| Capex IntensityCapex / Revenue | 12.5% | 5.6% |
| Cash ConversionOCF / Net Profit | 3.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | $55.3M | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.8M | — | ||
| Q3 25 | $12.9M | — | ||
| Q2 25 | $7.4M | — | ||
| Q1 25 | $2.2M | $-38.5M | ||
| Q4 24 | $26.0M | $-31.6M | ||
| Q3 24 | $9.8M | $-24.3M | ||
| Q2 24 | $6.4M | $39.8M | ||
| Q1 24 | $-1.5M | $-25.5M |
| Q4 25 | $34.6M | — | ||
| Q3 25 | $12.6M | — | ||
| Q2 25 | $7.2M | — | ||
| Q1 25 | $828.0K | $-39.7M | ||
| Q4 24 | $24.6M | $-32.2M | ||
| Q3 24 | $9.6M | $-24.9M | ||
| Q2 24 | $6.3M | $38.8M | ||
| Q1 24 | $-1.8M | $-26.4M |
| Q4 25 | 133.9% | — | ||
| Q3 25 | 51.4% | — | ||
| Q2 25 | 32.1% | — | ||
| Q1 25 | 3.8% | -192.9% | ||
| Q4 24 | 111.7% | -86.2% | ||
| Q3 24 | 47.0% | -127.3% | ||
| Q2 24 | 32.9% | 41.0% | ||
| Q1 24 | -9.8% | -44.6% |
| Q4 25 | 12.5% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 6.2% | 5.6% | ||
| Q4 24 | 6.7% | 1.7% | ||
| Q3 24 | 0.5% | 3.3% | ||
| Q2 24 | 0.3% | 1.1% | ||
| Q1 24 | 1.8% | 1.4% |
| Q4 25 | 3.72× | — | ||
| Q3 25 | 1.42× | — | ||
| Q2 25 | 0.91× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 3.58× | -27.94× | ||
| Q3 24 | 1.29× | — | ||
| Q2 24 | 1.03× | 0.72× | ||
| Q1 24 | -0.25× | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
